no chance of this being an issue.
These are the most common types of cancer, and the administration of a single dose of the CART is standard. The process for creating the CART is also defined GMP manufacturing guidelines.
in summary, easy to recruit patients, standard process for manufacturing and administration.
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-28
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $9.751M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $41.55K | 4.610M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1934891 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 2853536 | 6 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |